Digestive Disease Week
Digestive Disease Week
May 25, 2016
4 min watch
Save

VIDEO: IBS blood test gives physician, patient confidence in diagnosis

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN DIEGO — In this exclusive video from DDW 2016, Mark Pimentel, MD, from Cedars Sinai Medical Center, discusses the importance of IBSchek, a new blood test for irritable bowel syndrome.

“This biomarker was validated and presented last year at DDW, demonstrating that this antibody panel, anti-CdtB and anti-vinculin, can discriminate IBS from inflammatory bowel disease,” he said. “This would be one of the first biomarkers that says, if you have a patient coming to your office with diarrhea, if you do this, with greater than 95% certainty you have IBS. It’s important for a number of reasons: number one, the patient gets confident diagnosis; number two, IBS could be an organic disease.

“At this DDW, the test went on to be further validated and demonstrated that it is effective in diagnosing IBS-D and IBS-M, but not so well in IBS-C,” he added.

Reference:

Rezaie A, et al. Abstract #257. Presented at: Digestive Disease Week; May 21-24, 2016; San Diego.

Disclosures: Pimentel reports financial relationships with Salix, Synthetic Biologics, Naia Pharmaceuticals and Commonwealth Labs.